Urovo Technology Co., Ltd. (SHE:300531)
China · Delayed Price · Currency is CNY 17.44
-0.33 (-1.86%)
Jan 30, 2026, 3:04 PM CST
Urovo Technology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,462 | 1,221 | 1,268 | 1,411 | 1,417 | 1,159 |
Other Revenue | 0.29 | 0.29 | 0.03 | 0.43 | 0.04 | 0.24 |
| 1,462 | 1,221 | 1,268 | 1,411 | 1,417 | 1,159 | |
Revenue Growth (YoY) | 14.01% | -3.67% | -10.18% | -0.37% | 22.19% | 21.86% |
Cost of Revenue | 1,127 | 957.83 | 939.72 | 1,044 | 1,023 | 796.76 |
Gross Profit | 334.74 | 263.36 | 328.02 | 367.27 | 393.98 | 362.53 |
Selling, General & Admin | 169.84 | 171.71 | 168 | 157.51 | 158.38 | 143.15 |
Research & Development | 116.75 | 117.72 | 104.81 | 93.92 | 85.25 | 81.42 |
Other Operating Expenses | -2.59 | -14.57 | -27.09 | -15.28 | -20.13 | -5.52 |
Operating Expenses | 298.58 | 281.94 | 258.68 | 239.74 | 227.35 | 225.32 |
Operating Income | 36.16 | -18.58 | 69.34 | 127.53 | 166.63 | 137.21 |
Interest Expense | -9.63 | -15.85 | -12.61 | -8.24 | -7.32 | -6.47 |
Interest & Investment Income | 16.45 | 23.63 | 27.06 | 35.32 | 11.8 | 10.74 |
Currency Exchange Gain (Loss) | 0.76 | 0.76 | 15.63 | 4.18 | -5.03 | -5.96 |
Other Non Operating Income (Expenses) | 2.86 | -2.75 | -2.25 | -4.59 | -2.53 | -1.49 |
EBT Excluding Unusual Items | 46.61 | -12.78 | 97.17 | 154.21 | 163.56 | 134.03 |
Impairment of Goodwill | -114.19 | -114.19 | -257.13 | -86.48 | - | -9.92 |
Gain (Loss) on Sale of Investments | -15.25 | -23.84 | -12.89 | 82.49 | -2.78 | -4.21 |
Gain (Loss) on Sale of Assets | 1.12 | 0.93 | 0 | 0.06 | 0 | -0.02 |
Asset Writedown | -0.92 | -0.18 | -0.15 | -0.33 | -0.04 | -0.42 |
Legal Settlements | -0.06 | -0.06 | - | -0.1 | -3.01 | -1.55 |
Other Unusual Items | 9.09 | 10.36 | 13.09 | 14.82 | 7.44 | 13.38 |
Pretax Income | -73.6 | -139.75 | -159.91 | 164.67 | 165.17 | 131.29 |
Income Tax Expense | 9.92 | 10.79 | 7.13 | 8.59 | 11.64 | 13.14 |
Earnings From Continuing Operations | -83.52 | -150.54 | -167.04 | 156.07 | 153.53 | 118.15 |
Minority Interest in Earnings | 0.07 | 0.08 | 0.21 | 0.29 | 0.14 | 1.03 |
Net Income | -83.45 | -150.47 | -166.84 | 156.36 | 153.67 | 119.18 |
Net Income to Common | -83.45 | -150.47 | -166.84 | 156.36 | 153.67 | 119.18 |
Net Income Growth | - | - | - | 1.75% | 28.94% | 132.06% |
Shares Outstanding (Basic) | 326 | 328 | 329 | 333 | 334 | 322 |
Shares Outstanding (Diluted) | 326 | 328 | 329 | 333 | 334 | 322 |
Shares Change (YoY) | -0.44% | -0.43% | -0.99% | -0.41% | 3.71% | 12.90% |
EPS (Basic) | -0.26 | -0.46 | -0.51 | 0.47 | 0.46 | 0.37 |
EPS (Diluted) | -0.26 | -0.46 | -0.51 | 0.47 | 0.46 | 0.37 |
EPS Growth | - | - | - | 2.17% | 24.32% | 105.56% |
Free Cash Flow | -71.09 | -42.62 | 194.93 | 56.51 | 124.46 | 103.78 |
Free Cash Flow Per Share | -0.22 | -0.13 | 0.59 | 0.17 | 0.37 | 0.32 |
Dividend Per Share | 0.050 | 0.050 | 0.050 | 0.050 | 0.051 | 0.032 |
Dividend Growth | - | - | - | -1.02% | 57.51% | 0.22% |
Gross Margin | 22.89% | 21.57% | 25.87% | 26.02% | 27.81% | 31.27% |
Operating Margin | 2.47% | -1.52% | 5.47% | 9.04% | 11.76% | 11.84% |
Profit Margin | -5.71% | -12.32% | -13.16% | 11.08% | 10.85% | 10.28% |
Free Cash Flow Margin | -4.86% | -3.49% | 15.38% | 4.00% | 8.79% | 8.95% |
EBITDA | 47.54 | -7.51 | 79.99 | 138.65 | 179.84 | 152.9 |
EBITDA Margin | 3.25% | -0.61% | 6.31% | 9.82% | 12.70% | 13.19% |
D&A For EBITDA | 11.38 | 11.07 | 10.65 | 11.11 | 13.21 | 15.68 |
EBIT | 36.16 | -18.58 | 69.34 | 127.53 | 166.63 | 137.21 |
EBIT Margin | 2.47% | -1.52% | 5.47% | 9.04% | 11.76% | 11.84% |
Effective Tax Rate | - | - | - | 5.22% | 7.05% | 10.01% |
Revenue as Reported | 1,462 | 1,221 | 1,268 | 1,411 | 1,417 | 1,159 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.